Hospital nurse in Uganda dies in country's first Ebola outbreak in 2 years
KAMPALA, Uganda — A nurse in Uganda has died of Ebola in the first recorded fatality since the country's last outbreak of the disease ended in early 2023, a health official said.
The 32-year-old man was an employee of Mulago Hospital, the main referral facility in the capital, Kampala, Diana Atwine, permanent secretary of the health ministry, told reporters Thursday.
After developing a fever, he was treated at several locations in Uganda before multiple lab tests confirmed he had been suffering from Ebola. The man died on Wednesday and the Sudan strain of Ebola was confirmed following postmortem tests, Atwine said.
At least 44 contacts of the victim have been identified, including 30 health workers and patients at Mulago Hospital, according to Uganda's Ministry of Health.
The health authorities are 'in full control of the situation,' Atwine said, while also urging Ugandans to report any suspected cases.
Tracing contacts is key to stemming the spread of Ebola, and there are no approved vaccines for the Sudan strain of Ebola. Uganda's last outbreak, discovered in September 2022, killed at least 55 people before it was declared over in January 2023.
Confirmation of Ebola in Uganda is the latest in a trend of outbreaks of viral hemorrhagic fevers in east Africa. Tanzania declared an outbreak of the Ebola-like Marburg disease this month; in December, Rwanda announced that its outbreak of Marburg was over.
The World Health Organization will send an initial allocation of $1 million from a contingency fund to support Uganda's response, Tedros Adhanom Ghebreyesus, the WHO director-general, said in a brief statement posted on the social platform X.
'A full scale response is being initiated by the government and partners,' the statement said.
Kampala's outbreak could prove difficult to respond to, because the city has a highly mobile population of about 4 million. The nurse who died had sought treatment at a hospital just outside Kampala and later traveled to Mbale, in the country's east, where he was admitted in a public hospital. Health authorities said the man also sought the services of a traditional healer.
Emmanuel Batiibwe, a physician who helped lead Uganda's efforts to stop the country's 2022 outbreak, told the Associated Press that he expected a swift response in tracing all possible Ebola contacts in Kampala and elsewhere.
'Our reaction should be swift, decisive and well-coordinated,' he said, speaking of lessons learned from the 2022 outbreak, whose epicenter was a town in central Uganda. 'We have the means of responding quickly now.'
Ebola, which is spread by contact with bodily fluids of an infected person or contaminated materials, manifests as a deadly hemorrhagic fever. Symptoms include fever, vomiting, diarrhea, muscle pain and at times internal and external bleeding.
Scientists don't know the natural reservoir of Ebola, but they suspect the first person infected in an outbreak acquired the virus through contact with an infected animal or eating its raw meat. Ugandan officials are investigating the source of the current outbreak.
Uganda has had multiple Ebola outbreaks, including one in 2000 that killed hundreds. The 2014 to 2016 Ebola outbreak in West Africa killed more than 11,000 people, the disease's largest death toll.
Ebola was discovered in 1976 in two simultaneous outbreaks in South Sudan and Congo, where it occurred in a village near the Ebola River, after which the disease is named.
Muhumuza writes for the Associated Press.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
3 hours ago
- Newsweek
Map Shows States With Highest Levels of Tiny, Toxic Air Pollution
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. California and Oregon are among the U.S. hotspots for dangerous submicron (PM1) air pollution—those with particles less than a micron, or a millionth of a meter wide—according to new research. Researchers at Washington University of St. Louis have been quantifying the amount of submicron particles in the air across the country over the last 25 years. The data, which calculated submicron estimates based on known rations of what makes up PM 2.5 particles (those less than 2.5 microns wide), suggest that many areas in the east of the contiguous U.S. contain hotspots. Because PM1 pollution is much smaller than PM2.5 (and at least six times smaller than human blood cells), it has the potential to lead to even worse health effects, as it is small enough to slip past the body's defenses. Parts of Arizona, California, Idaho, New Mexico, Oregon and Texas all appear to have higher concentrations of submicron particulate matter, shown by darker red areas on the researchers' map, as below. A map of the U.S. showing the concentration of submicron particulate matter, with higher concentrations shown by darker red areas. A map of the U.S. showing the concentration of submicron particulate matter, with higher concentrations shown by darker red areas. Atmospheric Composition Analysis Group Conversely, parts of Colorado, Montana, Utah, and Wyoming appear to have far fewer dark patches on the map, suggesting much lower levels of submicron particulate matter. Parts of Arizona and New Mexico showed high concentration levels in some areas, and much lower levels among other regions of their respective state. Higher concentrations of PM1 were found in major urban and industrial areas and areas affected by wildfires, highlighting the role of combustion sources in producing harmful particles. This contrasts with lower concentrations being prevalent across the arid west. The World Health Organization (WHO) suggests that 99 percent of the global population breathes in air containing high levels of pollutants and exceeds the WHO guidelines. The combined effects of ambient air pollution with household air pollution are associated with 7 million premature deaths every year. Both outdoor and indoor air pollution can cause respiratory diseases, as the small particles are able to get deep into the lungs or potentially even into the bloodstream. Exposure to particle pollution can cause heart attacks, irregular heartbeat, aggravated asthma, decreased lung function, and difficulty breathing, according to the Environmental Protection Agency. According to Chi Li, assistant research professor and first author of the study, the small particles identified tend to come from direct air emissions, such as black carbon particles from diesel engines, or the smoke from wildfires. PM1 can also form through secondary processes however, when sulfur dioxide or nitrogen oxides are spit out through fuel combustion and burning coal, Li noted. The significance of pollution regulation should not be overlooked, as the dataset reveals that PM1 levels dropped sharply from 1998 to 2022, as a result of regulations such as the Clean Air Act of 1970. Newsweek has contacted Li via email for comment. Do you have a tip on a science story that Newsweek should be covering? Do you have a question about air pollution? Let us know via science@ Reference Li, C., Martin, R. V., Donkelaar, A. van, Jimenez, J. L., Zhang, Q., Turner, J. R., Liu, X., Rowe, M., Meng, J., Yu, W., & Thurston, G. D. (2025). Estimates of submicron particulate matter (PM1) concentrations for 1998–2022 across the contiguous USA: Leveraging measurements of PM1 with nationwide PM2·5 component data. The Lancet Planetary Health, 9(6).
Yahoo
4 hours ago
- Yahoo
Patient Temperature Monitoring Market worth US$3.85 billion by 2032 with 6.7% CAGR
DELRAY BEACH, Fla., June 16, 2025 /PRNewswire/ -- The global Patient Temperature Monitoring Market, valued at US$2.31 billion in 2024 stood at US$2.44 billion in 2025 and is projected to advance at a resilient CAGR of 6.7% from 2025 to 2032, culminating in a forecasted valuation of US$3.85 billion by the end of the period. The patient temperature monitoring market is experiencing substantial growth due to several pivotal factors. Key drivers include a burgeoning global population and an escalating incidence of infectious diseases. Furthermore, heightened awareness regarding the critical role of continuous temperature assessment is significantly influencing market dynamics. The increasing volume of surgical interventions also contributes to the rising demand for perioperative temperature monitoring solutions. Additionally, the market is bolstered by advancements in remote patient monitoring technologies within home healthcare environments. Several opportunities are emerging, particularly the intensified focus on enhancing healthcare infrastructure and the proliferation of digital health initiatives in developing economies. Integration of predictive analytics into vital sign monitoring systems represents another critical avenue for accelerating market expansion. Download PDF Brochure: Browse in-depth TOC on "Patient Temperature Monitoring Market" 577 - Tables57 - Figures471 - Pages By application, the patient temperature monitoring market is categorized based on application into pyrexia/fever, hypothermia, blood transfusion, anesthesia, and other applications. Notably, the pyrexia/fever segment held the largest share in 2024 and is anticipated to exhibit the highest growth rate throughout the forecast period. This trend is primarily driven by the elevated global incidence of infectious diseases and the pivotal role temperature monitoring plays in the early detection, diagnosis, and management of febrile illnesses. The surge in thermometer utilization within clinical environments and domestic settings, particularly during pandemics and seasonal outbreaks, has significantly heightened the demand for effective fever detection solutions. WHO reported 263 million cases of malaria and approximately 597,000 associated deaths in 2023, with 94% of cases concentrated in the African region. In contrast, the Centers for Disease Control and Prevention (CDC) documented 249 million malaria cases in 2022. These alarming statistics, highlighting fever as a critical diagnostic symptom, have catalyzed an increased deployment of digital and infrared thermometers in hospitals, outpatient facilities, and home care settings. By end user, the patient temperature monitoring market has been categorized by end user into various segments, including hospitals, home care settings, ambulatory care centers, urgent care centers, primary centers, and other end users. It is anticipated that hospitals commanded the largest market share in 2024, primarily due to their substantial patient intake, sophisticated infrastructure, and the routine implementation of temperature monitoring devices in critical areas such as emergency departments, intensive care units (ICUs), and surgical theatres. Hospitals depend on an array of temperature monitoring technologies to facilitate accurate diagnoses and manage perioperative care, solidifying their role as the principal environment for device deployment. The uptick in elective surgical procedures within public hospitals is further amplifying the demand for dependable patient temperature monitoring solutions. According to data from the Australian Institute of Health and Welfare (AIHW), public hospital admissions for elective surgeries hit a historic peak of 778,500 in 2023–24, reflecting a 5.8% increase from 735,500 in 2022–23. This rising surgical volume accentuates the criticality of robust temperature monitoring systems to ensure patient safety during the perioperative phase and mitigate the risk of complications, such as hypothermia, during hospitalization. By geography, the patient temperature monitoring market is categorized into five primary regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. As of 2024, North America has emerged as the predominant region in this market, primarily due to its sophisticated healthcare infrastructure and the rapid integration of novel medical technologies. Several factors contribute to this regional dominance, including heightened awareness surrounding early diagnosis, an increase in surgical procedures, and the growing prevalence of remote and continuous monitoring solutions. Additionally, the region's expanding geriatric demographic and the rising incidence of chronic conditions—often associated with symptoms such as fever, wounds, and cardiovascular events—further stimulate demand for temperature monitoring systems. Furthermore, the proliferation of surgical facilities is a significant driver, as is the presence of key industry players such as Cardinal Health, Baxter, and Helen of Troy in the North American market. Collectively, these elements are fostering robust growth in the patient temperature monitoring market within the US. Request Sample Pages : Prominent players in the patient temperature monitoring market include Koninklijke Philips N.V. (Netherlands), Cardinal Health (US), Baxter (Hill-Rom Holdings, Inc.) (US), Drägerwerk AG & Co. KGaA (Germany), Becton, Dickinson and Company (US), Omron Healthcare, Inc.(Japan), Masimo (US), Helen of Troy (US), Solventum (US), Terumo Corporation (Japan), Dongguan Actherm Medical Corp. (China), Hicks India (India), Microlife Corporation (Taiwan), Medtronic (Ireland), American Diagnostic Corporation (US), EASYTEM (South Korea), Thermomedics, Inc. (US), Cosinuss GmbH (Germany), A&D Company, Limited (US), Paul Hartmann AG (Germany), Geratherm Medical AG (Germany), Exergen (US), OMEGA Engineering Inc. (US), DeltaTrak Inc. (US), Beurer GmbH (Germany), Nureca (India), iHealth Labs Inc. (US), Kinsa Inc. (US), and Medisana GmbH (Germany). Koninklijke Philips N.V. (Netherlands): Koninklijke Philips N.V. (Philips) is positioned as a dominant player in the patient temperature monitoring sector in 2024. The company's global footprint spans over 100 countries, including key markets such as the US, China, India, Japan, France, Canada, and South Africa. Philips operates approximately 38 manufacturing facilities across 26 countries, with significant hubs in the Netherlands, Germany, the US, China, Finland, Israel, and Brazil. Philips has executed a series of strategic initiatives to strengthen and expand its presence in the domain of patient temperature monitoring. A noteworthy development occurred in April 2024, when Philips announced a strategic partnership to integrate SmartQare's innovative monitoring solution, viQtor, with its established clinical patient monitoring platforms. This collaboration represents a substantial leap toward implementing next-generation continuous patient monitoring technologies in both hospital and home care settings, with an initial deployment targeted in Europe. In light of the rapidly advancing landscape of healthcare, Philips has markedly increased its focus on R&D efforts aimed at boosting product efficacy and differentiation, ensuring its offerings remain at the forefront of the market. Cardinal Health (US) Cardinal Health ranks as the second leading entity in the patient temperature monitoring sector, holding a substantial market share projected for 2024. As a prominent healthcare services and product provider, the company delivers tailored solutions to a diverse range of stakeholders, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician practices. The company boasts a robust international presence, particularly in North America, Europe, the Middle East, and Africa, underpinned by an extensive distribution network that spans key geographic markets such as the US, the UK, Switzerland, Sweden, Spain, the Netherlands, Italy, Germany, Ireland, Denmark, Croatia, Belgium, and France. Cardinal Health's competitive advantages stem from its strong geographic distribution capabilities, a technologically diverse and innovative product portfolio, and an established logistics framework. This strategic positioning allows the company to effectively address the diverse and evolving needs of healthcare providers across its operational territories. Baxter (Hill-Rom Holdings, Inc.) (US) Baxter (Hill-Rom Holdings, Inc.) has established itself as the third leading entity in the patient temperature monitoring market as of 2024. The company plays a critical role in this sector, capitalizing on its solid market presence, which is substantiated by strong sales performance and a comprehensive product portfolio that includes handheld, ear, and veterinary thermometers. Baxter's diverse array of offerings, paired with an extensive global distribution network, allows for effective penetration in various international markets. The company's geographical footprint includes a substantial presence in the US as well as other strategic regions. Its R&D capabilities are significant, with facilities located in the US, Germany, Singapore, Italy, and France. Furthermore, Baxter allocates a considerable portion of its revenue to R&D, fostering ongoing innovation and the development of advanced solutions tailored to the evolving needs of the patient temperature monitoring landscape. For more information, Inquire Now! Related Reports: Temperature Monitoring Systems Market Patient Monitoring Devices Market Brain Monitoring Market Veterinary Equipment and Supplies Market Wearable Healthcare Devices Market Get access to the latest updates on Patient Temperature Monitoring Companies and Patient Temperature Monitoring Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content to download multimedia: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Getting in more steps may prevent the leading cause of disability in the US, study says
Sign up for CNN's Fitness, But Better newsletter series. Our seven-part guide will help you ease into a healthy routine, backed by experts. Getting your steps in is good for your health, but it may also help keep you from being affected by disability later, new research has found. Walking 100 minutes a day was associated with a 23% reduced risk of chronic low back pain, according to a study published Friday in the journal JAMA Network Open. 'This is an important finding because walking is a simple, low cost, and accessible activity that can be promoted widely to reduce the burden of low back pain,' said lead study author Rayane Haddadj, a doctoral candidate in the department of public health and nursing at the Norwegian University of Science and Technology, in an email. An estimated 600 million people worldwide experience low back pain, which is considered the leading cause of disability, said physiotherapist Dr. Natasha Pocovi, a postdoctoral research fellow in health sciences at Macquarie University in Sydney. She was not involved in the research. By 2050, the number of people with chronic low back pain is expected to grow to 843 million, according to the World Health Organization. And yet prevention of low back pain is often overlooked in research and clinical practice, Pocovi added. The results from this latest study show there is the possibility of using physical activity as prevention. Pocovi said the research also 'suggests that we don't need to complicate our exercise routines to protect ourselves against chronic low back pain.' To investigate the connection between walking and back pain prevention, the research team analyzed data from more than 11,000 participants age 20 and older from the Trøndelag Health, or HUNT, Study in Norway. Between 2017 and 2019, HUNT researchers asked study participants to wear accelerometers for seven days to track their walking patterns. The HUNT team then followed up from 2021 and 2023 and asked if participants experienced back pain, according to the new study. People were divided into four groups: those who walked less than 78 minutes in a day, 78 to 100 minutes, 101 to 124 minutes, and more than 125 minutes. The findings showed that as the amount of daily walking increased, the risk of chronic low back pain decreased, and preliminary evidence revealed moderate or brisk walking was more protective than a slow pace, Pocovi said. There are reasons to have confidence in the study results, including the large sample size and the use of accelerometers instead of people reporting their own levels of physical activity, she added. However, the walking data was only captured over one week, which might not be reflective of people's patterns over a month or year, Pocovi said. The study is also observational, which means that while it can show associations, researchers can't say for sure that the walking caused reduced risk of low back pain. Not only is low back pain a leading cause of disability –– it's also expensive. On average, people spend more than $30,000 on back pain-related costs over the five years after first diagnosis, according to an April 2024 study. Easy, inexpensive changes that prevent chronic low back pain can make a big difference, Haddadj said. The study wasn't able to address if walking 100 minutes straight had more, less or the same impact as accumulating that same amount of time in short bursts, Pocovi said. But in most cases, unless there is an underlying medical condition, any amount of walking is better than none, Pocovi said. 'Start with short walking sessions, either by planning specific walks or finding small ways to integrate a brief stroll into your daily routine,' she said. She likes to take stairs instead of the elevator or walk to a coffee shop a little farther from her home, Pocovi said. 'The key is to gradually increase your walking in a sustainable and enjoyable way,' she said in an email. 'Additionally, it can be helpful to have a friend, partner, or colleague join you for walks to keep yourself motivated and accountable.' You can add walking as a way to spend time with friends in addition to dinner and drinks, CNN fitness contributor Dana Santas, a certified strength and conditioning specialist and mind-body coach in professional sports, said in a previous article. And if you want to move past getting a couple of extra steps and get more physical activity, you can still start small and build your way up, Santas said. Some workouts can even be completed from the comfort of your couch while watching an episode of your favorite TV show, she added.